Elanco Animal Health, Inc. (ELAN)
24.06
+1.19
(+5.20%)
USD |
NYSE |
Jun 11, 16:00
24.06
0.00 (0.00%)
After-Hours: 17:58
Elanco Animal Health SG&A Expense (Quarterly) : 381.00M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 381.00M |
| December 31, 2025 | 338.00M |
| September 30, 2025 | 351.00M |
| June 30, 2025 | 400.00M |
| March 31, 2025 | 341.00M |
| December 31, 2024 | 300.00M |
| September 30, 2024 | 323.00M |
| June 30, 2024 | 354.00M |
| March 31, 2024 | 337.00M |
| December 31, 2023 | 292.00M |
| September 30, 2023 | 313.00M |
| June 30, 2023 | 353.00M |
| March 31, 2023 | 327.00M |
| December 31, 2022 | 303.00M |
| September 30, 2022 | 298.00M |
| June 30, 2022 | 343.00M |
| March 31, 2022 | 323.00M |
| Date | Value |
|---|---|
| December 31, 2021 | 327.00M |
| September 30, 2021 | 342.00M |
| June 30, 2021 | 385.00M |
| March 31, 2021 | 348.00M |
| December 31, 2020 | 374.10M |
| September 30, 2020 | 277.70M |
| June 30, 2020 | 162.80M |
| March 31, 2020 | 182.00M |
| December 31, 2019 | 185.90M |
| September 30, 2019 | 192.30M |
| June 30, 2019 | 200.90M |
| March 31, 2019 | 181.10M |
| December 31, 2018 | 185.10M |
| September 30, 2018 | 179.00M |
| June 30, 2018 | 191.10M |
| March 31, 2018 | 180.00M |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Zoetis, Inc. | 588.00M |
| Eli Lilly & Co. | 2.934B |
| Phibro Animal Health Corp. | 81.02M |
| Royalty Pharma Plc | 159.49M |
| ANI Pharmaceuticals, Inc. | 73.66M |